Lorne Allan Ben Babiuk

Lorne Allan Ben Babiuk's AcademicInfluence.com Rankings

Biology

#5533

World Rank

#8038

Historical Rank

Microbiology

#215

World Rank

#254

Historical Rank

Immunology

#264

World Rank

#275

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Lorne Allan Ben Babiuk Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lorne Allan Ben Babiuk's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mechanisms of Action of Adjuvants (2013) (506)
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. (2010) (364)
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA (1993) (352)
The use of fluorescein isothiocyanate in the determination of the bacterial biomass of grassland soil. (1970) (303)
Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. (1995) (272)
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. (2001) (248)
Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. (2009) (235)
Review: Capripoxvirus Diseases: Current Status and Opportunities for Control (2015) (225)
Serum haptoglobin as an indicator of the acute phase response in bovine respiratory disease (1996) (208)
Induction of a Novel Chicken Toll-Like Receptor following Salmonella enterica Serovar Typhimurium Infection (2006) (200)
Induction of immune responses by DNA vaccines in large animals. (2003) (186)
Electroporation improves the efficacy of DNA vaccines in large animals. (2002) (186)
Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. (2004) (183)
Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. (2007) (176)
Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. (2007) (174)
Rotavirus isolation and cultivation in the presence of trypsin (1977) (168)
Genome-wide Expression Analyses of Campylobacter jejuni NCTC11168 Reveals Coordinate Regulation of Motility and Virulence by flhA*[boxs] (2004) (164)
Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs (2003) (157)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. (2006) (156)
Severe acute respiratory syndrome (SARS): a year in review. (2005) (153)
Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. (2007) (153)
Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. (2000) (151)
Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference (2004) (145)
Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. (1998) (143)
Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. (2001) (139)
Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells (1990) (137)
Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. (2004) (137)
Effect of Stress on Viral–Bacterial Synergy in Bovine Respiratory Disease: Novel Mechanisms to Regulate Inflammation (2005) (135)
Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins (1979) (134)
Immunology of bovine herpesvirus 1 infection. (1996) (131)
SH3 Binding Motif 1 in Influenza A Virus NS1 Protein Is Essential for PI3K/Akt Signaling Pathway Activation (2007) (130)
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization (2009) (130)
Biological activity of immunostimulatory CpG DNA motifs in domestic animals. (2003) (128)
The Immunogenicity and Protective Efficacy of Bovine Herpesvirus 1 Glycoprotein D plus Emulsigen Are Increased by Formulation with CpG Oligodeoxynucleotides (2002) (127)
Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves (1983) (123)
CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. (2002) (119)
Viral-bacterial pneumonia in calves: effect of bovine herpesvirus-1 on immunologic functions. (1985) (118)
Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. (1993) (116)
Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. (2008) (116)
Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide (2006) (115)
TLR9−/− and TLR9+/+ mice display similar immune responses to a DNA vaccine (2004) (114)
Replication-Defective Bovine Adenovirus Type 3 as an Expression Vector (1999) (110)
Nucleotide sequence of bovine herpesvirus type 1 glycoprotein gIII, a structural model for gIII as a new member of the immunoglobulin superfamily, and implications for the homologous glycoproteins of other herpesviruses. (1989) (104)
Monoclonal antibodies to bovine coronavirus: Characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins☆ (1987) (104)
Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone (1980) (103)
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens. (2007) (101)
Altering the Cellular Location of an Antigen Expressed by a DNA-Based Vaccine Modulates the Immune Response (1999) (99)
Quantitative, Competitive PCR Analysis of Porcine Circovirus DNA in Serum from Pigs with Postweaning Multisystemic Wasting Syndrome (2000) (95)
Swine outbreak of pandemic influenza A virus on a Canadian research farm supports human-to-swine transmission. (2011) (94)
Genome to Kinome: Species-Specific Peptide Arrays for Kinome Analysis (2009) (94)
Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. (2003) (92)
Combination adjuvants: the next generation of adjuvants? (2011) (92)
A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. (2009) (91)
The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. (1990) (91)
DNA vaccines: a review. (1999) (89)
Peste des Petits Ruminants Virus Tissue Tropism and Pathogenesis in Sheep and Goats following Experimental Infection (2014) (89)
Nucleotide Sequence, Genome Organization, and Transcription Map of Bovine Adenovirus Type 3 (1998) (89)
Gene Gun-Mediated DNA Immunization Primes Development of Mucosal Immunity against Bovine Herpesvirus 1 in Cattle (2000) (89)
ArrayPipe: a flexible processing pipeline for microarray data (2004) (89)
Polynucleotide vaccines in animals: enhancing and modulating responses. (1997) (88)
Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres. (2002) (88)
The Host Defense Peptide Beta-Defensin 1 Confers Protection against Bordetella pertussis in Newborn Piglets (2006) (86)
A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. (1994) (86)
Approaches to Enhance the Efficacy of DNA Vaccines (2004) (85)
Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. (1990) (84)
Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. (1999) (84)
Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. (2002) (83)
Fetal immunization by a DNA vaccine delivered into the oral cavity (2000) (83)
Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB (1995) (82)
Nuclear Localization of the ORF 2 Protein Encoded by Porcine Circovirus Type 2 (2001) (81)
Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. (2002) (80)
Development of a bovine adenovirus type 3-based expression vector. (1995) (80)
Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. (2005) (79)
Mucosal delivery of vaccines in domestic animals. (2006) (79)
Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis (1975) (79)
Viral-Bacterial Synergistic Interaction in Respiratory Disease (1988) (78)
Immunization of animals: from DNA to the dinner plate. (1999) (78)
Protection of Neonatal Chicks Against a Lethal Challenge of Escherichia coli Using DNA Containing Cytosine-Phosphodiester-Guanine Motifs (2004) (77)
Genomic and Protein Structural Maps of Adaptive Evolution of Human Influenza A Virus to Increased Virulence in the Mouse (2011) (77)
Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. (1999) (76)
Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses (1976) (76)
Chronic shedding of bovine enteric coronavirus antigen-antibody complexes by clinically normal cows. (1985) (75)
TEST FOR REOVIRUS-LIKE AGENT (1975) (75)
Effect of bovine alpha 1 interferon on bovine herpesvirus type 1-induced respiratory disease. (1985) (75)
Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice. (2005) (73)
Cytokine activity in bovine mammary gland secretions during the periparturient period. (1991) (73)
Broadening the approaches to developing more effective vaccines. (1999) (72)
Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses. (2000) (72)
Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis. (2011) (72)
CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. (2002) (71)
Strategies for improved formulation and delivery of DNA vaccines to veterinary target species (2004) (71)
Protection of Neonatal Broiler Chicks Against Salmonella Typhimurium Septicemia by DNA Containing CpG Motifs (2008) (71)
T lymphocyte population dynamics and function following a primary bovine herpesvirus type-1 infection. (1987) (70)
The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. (2009) (70)
Transcriptional and translational expression patterns associated with immobilized growth of Campylobacter jejuni. (2006) (69)
Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells (1976) (68)
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine (2006) (68)
Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. (1974) (67)
Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles. (2012) (67)
Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides (2006) (66)
Maternal Immunity Provides Protection against Pertussis in Newborn Piglets (2006) (66)
Vaccination of Cattle with a CpG Oligodeoxynucleotide-Formulated Mycobacterial Protein Vaccine and Mycobacterium bovis BCG Induces Levels of Protection against Bovine Tuberculosis Superior to Those Induced by Vaccination with BCG Alone (2005) (66)
Development of porcine adenovirus-3 as an expression vector. (1999) (66)
Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides. (2009) (66)
Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway. (2010) (65)
Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen. (2008) (64)
The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells (1991) (64)
Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein (1996) (64)
Cloning and in vitro expression of the gene for the E3 haemagglutinin glycoprotein of bovine coronavirus. (1989) (62)
CpG Oligodeoxynucleotides Activate Innate Immune Response that Suppresses Infectious Bronchitis Virus Replication in Chicken Embryos (2009) (62)
Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines (2005) (61)
Nonspecific suppressive effect of bovine herpesvirus type 1 on bovine leukocyte functions (1983) (61)
Infection of Newborn Piglets with Bordetella pertussis: a New Model for Pertussis (2005) (61)
Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants. (2004) (61)
Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD. (1998) (61)
Mechanisms of recovery from Herpesvirus infections -a review. (1978) (61)
Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. (2011) (61)
Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth (1995) (60)
Oligodeoxynucleotides containing CpG motifs (CpG-ODN) predominantly induce Th1-type immune response in neonatal chicks. (2008) (60)
Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression. (2005) (60)
Monoclonal antibodies to bovine coronavirus glycoproteins E2 and E3: demonstration of in vivo virus-neutralizing activity. (1989) (60)
Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. (1993) (59)
Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod. (2008) (59)
Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. (2000) (59)
Ontogeny of the immune response: effect of protein energy malnutrition in neonatal calves. (1987) (58)
High transfection efficiency, gene expression, and viability of monocyte‐derived human dendritic cells after nonviral gene transfer (2007) (58)
Alteration of some leukocyte functions following in vivo and in vitro exposure to recombinant bovine alpha- and gamma-interferon. (1986) (58)
The possible role of stress in the induction of pneumonic pasteurellosis. (1984) (58)
Elastase-Dependent Live Attenuated Swine Influenza A Viruses Are Immunogenic and Confer Protection against Swine Influenza A Virus Infection in Pigs (2009) (57)
Bovine peripheral blood leukocyte subpopulation dynamics following a primary bovine herpesvirus-1 infection. (1987) (57)
Viral-bacterial pneumonia in calves: duration of the interaction between bovine herpesvirus 1 and Pasteurella haemolytica. (1983) (57)
Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation. (1998) (57)
In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. (2004) (56)
Comparative analysis of innate immune responses following infection of newborn calves with bovine rotavirus and bovine coronavirus. (2007) (56)
Lymphocyte proliferative responses to separated bovine herpesvirus 1 proteins in immune cattle (1990) (56)
CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. (2009) (56)
Topographical analysis of bovine herpesvirus type-1 glycoproteins: use of monoclonal antibodies to identify and characterize functional epitopes. (1985) (56)
Use of animal models in the development of human vaccines. (2007) (56)
Multiple intestinal 'loops' provide an in vivo model to analyse multiple mucosal immune responses. (2001) (55)
Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide. (2003) (55)
Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. (1975) (55)
Effect of infectious bovine rhinotracheitis virus infection on bovine alveolar macrophage function (1982) (55)
Effect of Chronic Administration of Recombinant Bovine Tumor Necrosis Factor to Cattle (1989) (55)
Nucleic acid vaccines: research tool or commercial reality. (2000) (54)
Targeting with Bovine CD154 Enhances Humoral Immune Responses Induced by a DNA Vaccine in Sheep1 (2003) (54)
Identification and deletion mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes simplex virus UL49.5. (1993) (54)
Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. (1993) (54)
Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection. (2008) (54)
Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. (2010) (54)
Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins (1991) (54)
Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins GVP 3/9 and GVP 6/11a/16, purified by immunoadsorbent chromatography. (1985) (53)
Modulation of bovine mammary neutrophil function during the periparturient period following in vitro exposure to recombinant bovine interferon gamma. (1991) (53)
Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. (1999) (53)
Oral DNA Vaccination In Utero Induces Mucosal Immunity and Immune Memory in the Neonate1 (2002) (53)
Stress significantly increases mortality following a secondary bacterial respiratory infection (2012) (53)
Bovine herpesvirus‐1 vaccines (1993) (52)
Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity (1977) (52)
Characterization of bovine Toll-like receptor 8: ligand specificity, signaling essential sites and dimerization. (2009) (52)
Porcine adenovirus-3 as a helper-dependent expression vector. (1999) (51)
Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-alpha 1) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 1. (1984) (51)
Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. (1993) (51)
Novel vaccines from biotechnology. (2005) (51)
Regulation of bovine acute phase responses by recombinant interleukin-1 beta. (1995) (51)
Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D. (1997) (51)
The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-gamma. (2000) (50)
Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. (2001) (50)
The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1. (1999) (50)
An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. (1992) (50)
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis. (2005) (49)
Nucleotide sequence and transcription map of porcine adenovirus type 3. (1998) (49)
Structure of the polysaccharide chain of Pasteurella haemolytica (serotype 4) lipopolysaccharide (1984) (49)
Formulation with CpG Oligodeoxynucleotides Prevents Induction of Pulmonary Immunopathology following Priming with Formalin-Inactivated or Commercial Killed Bovine Respiratory Syncytial Virus Vaccine (2005) (49)
Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. (2001) (49)
Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins. (1993) (49)
Molecular cloning and expression of bovine interleukin-8. (1996) (48)
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections. (1976) (48)
The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. (1977) (47)
Electron microscopic description of glycocalyx and fimbriae on the surface of Pasteurella haemolytica-A1. (1987) (47)
Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice. (2016) (47)
Bovid herpesvirus type-1 (infectious bovine rhinotracheitis virus)-induced thymidine kinase. (1982) (47)
Comparative approaches to the investigation of responses to stress and viral infection in cattle. (2007) (47)
Controlling acute Escherichia coli mastitis during the periparturient period with recombinant bovine interferon gamma. (1991) (46)
Role of bovine adenovirus-3 33K protein in viral replication. (2004) (46)
Modulation of immune responses to bovine herpesvirus‐1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154 (2004) (46)
Antibacterial activity of bovine mammary gland lymphocytes following treatment with interleukin-2. (1991) (46)
Th1/Th2 biasing effects of vaccination in cattle as determined by real-time PCR. (2002) (46)
Activation of adjuvant core response genes by the novel adjuvant PCEP. (2012) (46)
Cytokine profiles following interaction between bovine alveolar macrophages and Pasteurella haemolytica. (1999) (46)
Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle. (1997) (46)
Biomarkers for prediction of bovine respiratory disease outcome. (2009) (45)
Comparison of the Antiviral Effects of 5-Methoxymethyl-deoxyuridine with 5-Iododeoxyuridine, Cytosine Arabinoside, and Adenine Arabinoside (1975) (45)
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. (2013) (45)
Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows. (1987) (45)
Diagnosing and managing the respiratory form of infectious bovine rhinotracheitis (1991) (45)
Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils. (1980) (44)
Further analysis of the role of calcium in rotavirus morphogenesis. (1987) (44)
Effect of bovine recombinant alpha-1 interferon on inflammatory responses of bovine phagocytes. (1984) (44)
Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle. (2006) (44)
Vaccine delivery: lipid-based delivery systems. (2000) (44)
Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs. (2009) (44)
Characterization of surface receptors on bovine leukocytes. (1978) (44)
Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD. (1996) (44)
Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells (2003) (43)
The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents. (2010) (43)
Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets. (2011) (43)
Vaccine Potentiation by Combination Adjuvants (2014) (43)
A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. (2007) (43)
Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. (2004) (43)
Vaccination: a management tool in veterinary medicine. (2002) (43)
Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. (2005) (43)
Bovine polymorphonuclear cells passively acquire membrane lipids and integral membrane proteins from apoptotic and necrotic cells (2006) (42)
Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix). (2003) (42)
Hemagglutination and hemagglutination-inhibition studies with a strain of Nebraska calf diarrhea virus (bovine rotavirus). (1978) (42)
Viral infections in domestic animals as models for studies of viral immunology and pathogenesis. (1986) (42)
Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes. (1975) (42)
Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy. (2008) (42)
Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells (1988) (42)
Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1 (1987) (42)
The mammary gland of the ox: a convenient source for the repeated collection of neutrophils and macrophages. (1976) (42)
Establishment of fetal bovine intestinal epithelial cell cultures susceptible to bovine rotavirus infection (2008) (42)
Antibody dependent cytotoxicity mediated by neutrophils: a possible mechanism of antiviral defense. (1976) (41)
Capture immunoassay for ruminant tumor necrosis factor-α: comparison with bioassay (1993) (41)
Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection. (1997) (41)
Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells. (2007) (41)
Extended sequencing of vaccine and wild-type capripoxvirus isolates provides insights into genes modulating virulence and host range. (2019) (41)
Characterization of a bovine lactoferrin binding protein of Streptococcus uberis. (2003) (41)
Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro‐inversed isomers (2011) (40)
Role of interferon-γ in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells (1989) (40)
Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. (2000) (40)
Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats. (2000) (40)
Characterization of nuclear localization and export signals of the major tegument protein VP8 of bovine herpesvirus-1. (2004) (40)
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children (2016) (39)
Innate immunity and new adjuvants. (2007) (39)
Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV. (1992) (39)
Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens. (2009) (39)
Protective immunity in cattle following vaccination with conventional and marker bovine herpesvirus-1 (BHV1) vaccines. (1997) (39)
Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8* produced in plants using a TMV-based vector (2004) (39)
Application of interferons in the control of infectious diseases of cattle. (1991) (38)
Strategies to link innate and adaptive immunity when designing vaccine adjuvants. (2009) (38)
The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle. (2000) (38)
Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens. (2010) (38)
A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep. (2007) (38)
Aggregate content influences the Th1/Th2 immune response to influenza vaccine: Evidence from a mouse model (2004) (38)
Cloning, sequencing and expression of the CAMP factor gene ofStreptococcus uberis☆ (1996) (38)
PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice. (2010) (38)
Evidence for defective neutrophil function in lungs of calves exposed to infectious bovine rhinotracheitis virus. (1984) (38)
Immunization of livestock with DNA vaccines: current studies and future prospects. (2001) (37)
Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. (2006) (37)
Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses (1993) (37)
Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins. (1991) (37)
The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity. (1995) (37)
Bovine monocytes and macrophages: an accessory role in suppressor-cell generation by Con A and in lectin-induced proliferation. (1983) (37)
Seroprevalence of porcine circovirus type 2 in swine populations in Canada and Costa Rica. (2002) (37)
Identification and transcriptional analysis of a 3'-coterminal gene cluster containing UL1, UL2, UL3, and UL3.5 open reading frames of bovine herpesvirus-1. (1995) (36)
Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1. (2010) (36)
Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). (1995) (36)
CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep. (2004) (36)
CpG-ODNs induced changes in cytokine/chemokines genes expression associated with suppression of infectious bronchitis virus replication in chicken lungs (2014) (36)
Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. (2006) (35)
Delineation of the essential function of bovine herpesvirus 1 gD: an indication for the modulatory role of gD in virus entry. (1995) (35)
Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses. (2010) (35)
Primary structure of the S peplomer gene of bovine coronavirus and surface expression in insect cells. (1990) (35)
Glycoprotein H (gII/gp108) and glycoprotein L form a functional complex which plays a role in penetration, but not in attachment, of bovine herpesvirus 1. (1996) (35)
Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus. (2006) (35)
Adenovirus-mediated TNF-α gene transfer induces significant tumor regression in mice (1999) (35)
Cloning, sequencing and expression of the CAMP factor gene of Streptococcus uberis. (1996) (35)
Alteration of alveolar macrophage functions after aerosol infection with bovine herpesvirus type 1 (1986) (34)
Comparative virulence of different bovine rotavirus isolates. (1981) (34)
Immune control of herpesvirus latency. (1979) (34)
Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding. (2006) (34)
The role of carbohydrate in the antigenic and immunogenic structure of bovine herpesvirus type 1 glycoproteins gI and gIV. (1990) (34)
A UL47 Gene Deletion Mutant of Bovine Herpesvirus Type 1 Exhibits Impaired Growth in Cell Culture and Lack of Virulence in Cattle (2009) (34)
Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection. (1982) (34)
Enhanced immune response to an intradermally delivered DNA vaccine expressing a secreted form of BHV-1 gD (1997) (33)
A comparison between isolated blood dendritic cells and monocyte‐derived dendritic cells in pigs (2010) (33)
Susceptibility of bovine macrophages to infectious bovine rhinotracheitis virus infection (1982) (33)
Transcriptional analysis of avian embryonic tissues following infection with avian infectious bronchitis virus (2005) (33)
Intranasal Immunization of Mice with a Bovine Respiratory Syncytial Virus Vaccine Induces Superior Immunity and Protection Compared to Those by Subcutaneous Delivery or Combinations of Intranasal and Subcutaneous Prime-Boost Strategies (2009) (33)
Mapping of 10 epitopes on bovine herpesvirus type 1 glycoproteins gI and gIII. (1990) (33)
A novel combination adjuvant platform for human and animal vaccines. (2017) (33)
Comparison of rotavirus strains by hemagglutination inhibition. (1978) (33)
Capripoxvirus-vectored vaccines against livestock diseases in Africa. (2013) (32)
Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle. (1995) (32)
The Effects of Dietary T-2 Toxin on Acute Herpes Simplex Virus Type 1 Infection in Mice (1983) (32)
Mechanisms of recovery from viral infections: destruction of infected cells by neutrophils and complement. (1980) (32)
Induction of immune responses to bovine herpesvirus type 1 gD in passively immune mice after immunization with a DNA-based vaccine. (1999) (32)
Species selective interaction of Alphaherpesvirinae with the “unspecific” immune system of the host (2005) (32)
Influence of interferons alpha I1 and gamma and of tumour necrosis factor on persistent infection with bovine viral diarrhoea virus in vitro. (1988) (32)
Delivery of DNA vaccines using electroporation. (2006) (32)
Cytokine synergy with viral cytopathic effects and bacterial products during the pathogenesis of respiratory tract infection. (1991) (32)
Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica. (1983) (32)
Induction, regulation and physiological role of IL-17 secreting helper T-cells isolated from PBMC, thymus, and lung lymphocytes of young pigs. (2011) (31)
Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement (1977) (31)
The role of neutrophils in antiviral defense--in vitro studies on the mechanism of antiviral inhibition. (1977) (31)
Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle. (2001) (31)
Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS. (2011) (31)
Formulation of bovine respiratory syncytial virus fusion protein with CpG oligodeoxynucleotide, cationic host defence peptide and polyphosphazene enhances humoral and cellular responses and induces a protective type 1 immune response in mice. (2009) (31)
Nucleic Acids Exert a Sequence-independent Cooperative Effect on Sequence-dependent Activation of Toll-like Receptor 9* (2007) (31)
Protection of Chickens Against a Lethal Challenge of Escherichia coli by a Vaccine Containing CpG Oligodeoxynucleotides as an Adjuvant (2007) (31)
Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. (2005) (31)
Differential activation and maturation of two porcine DC populations following TLR ligand stimulation. (2010) (30)
Immunogenicity of Bovine Herpes virus 1 Glycoprotein D in Mice: Effect of Antigen Form on the Induction of Cellular and Humoral Immune Responses (1996) (30)
An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine. (2011) (30)
Analysis of bovine herpes virus-type 1 isolates by restriction endonuclease fingerprinting (2005) (30)
Kinome analysis of Toll-like receptor signaling in bovine monocytes (2009) (30)
Inhibition of antigen-induced and interleukin-2-induced proliferation of bovine peripheral blood leukocytes by inactivated bovine herpes virus 1 (1990) (30)
Expression and secretion of the bovine coronavirus hemagglutinin-esterase glycoprotein by insect cells infected with recombinant baculoviruses (1990) (30)
A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats. (2015) (30)
Novel vaccine strategies. (2002) (29)
Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D. (1999) (29)
Erythrocyte rosettes--a marker for bovine T cells. (1976) (29)
Complement enhances antiviral antibody-dependent cell cytotoxicity (1977) (29)
Host Defense Mechanisms Against Infectious Bovine Rhinotracheitis Virus: In Vitro Stimulation of Sensitized Lymphocytes by Virus Antigen (1974) (29)
Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs (2005) (29)
The complete nucleotide sequence of bovine rotavirus C486 gene 4 cDNA. (1987) (29)
Characterization of the Nuclear Localization and Nuclear Export Signals of Bovine Herpesvirus 1 VP22 (2005) (29)
Characterization of early region 1 and pIX of bovine adenovirus-3. (1999) (29)
Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs. (2012) (29)
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens (2010) (29)
Microparticles for oral delivery of vaccines (2005) (28)
Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits. (2003) (28)
Bovine type II interferon: activity in heterologous cells. (1977) (28)
Effects of recombinant granulocyte-macrophage colony-stimulating factor on bovine peripheral blood and mammary gland neutrophil function in vitro. (1992) (28)
A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNα responses (2009) (28)
A monoclonal antibody detects macrophage maturation antigen which appears independently of class II antigen expression. Reactivity of monoclonal EBM11 with bovine macrophages. (1988) (28)
Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. (2007) (28)
'Integration' of polyoma virus DNA into mammalian genomes. (1972) (28)
Bovine Herpesvirus 1 VP22 Enhances the Efficacy of a DNA Vaccine in Cattle (2005) (28)
Genomics-Based Molecular Epidemiology of Campylobacter jejuni Isolates from Feedlot Cattle and from People in Alberta, Canada (2008) (28)
The growth phase-dependent regulation of the pilus locus genes by two-component system TCS08 in Streptococcus pneumoniae. (2009) (27)
Porcine Neonatal Blood Dendritic Cells, but Not Monocytes, Are More Responsive to TLRs Stimulation than Their Adult Counterparts (2013) (27)
Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine. (2001) (27)
Major tegument protein VP8 of bovine herpesvirus 1 is phosphorylated by viral US3 and cellular CK2 protein kinases. (2009) (27)
Transcription mapping and characterization of 284R and 121R proteins produced from early region 3 of bovine adenovirus type 3. (1999) (27)
Induction of receptors for complement and immunoglobulins by herpesviruses of various species. (1988) (27)
Effect of infectious bovine rhinotracheitis virus infection of calves on cell populations recovered by lung lavage. (1982) (27)
DNA Immunization with Bovine Herpesvirus‐1 Genes a (1995) (27)
HDAC6 Restricts Influenza A Virus by Deacetylation of the RNA Polymerase PA Subunit (2018) (26)
The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization (2002) (26)
Bovine Alveolar Macrophages: Phenotypic and Functional Properties of Subpopulations Obtained by Percoll Density Gradient Centrifugation (1986) (26)
Expression of bovine herpesvirus type 1 glycoprotein gI in transfected bovine cells induces spontaneous cell fusion. (1990) (26)
Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus. (2001) (26)
Structural analysis of the conformational domains involved in neutralization of bovine coronavirus using deletion mutants of the spike glycoprotein S1 subunit expressed by recombinant baculoviruses (1991) (26)
Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2. (1991) (26)
Identification of genomic differences between Escherichia coli strains pathogenic for poultry and E. coli K-12 MG1655 using suppression subtractive hybridization analysis. (2002) (26)
Streptococcus pneumoniae early response genes to human lung epithelial cells (2008) (26)
Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties (1991) (26)
Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D. (2006) (26)
Hepatitis C virus non-structural protein-2 activates CXCL-8 transcription through NF-κB (2007) (26)
Intracellular localization of the SARS coronavirus protein 9b: Evidence of active export from the nucleus (2007) (25)
Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH. (1996) (25)
Detection by radioimmunoassay and enzyme-linked immunosorbent assay of coronavirus antibodies in bovine serum and lacteal secretions (1982) (25)
Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV (1993) (25)
Effect of Haemophilus somnus on phagocytosis and hydrogen peroxide production by bovine polymorphonuclear leukocytes. (1992) (25)
Transcription map and expression of bovine herpesvirus-1 glycoprotein D in early region 4 of bovine adenovirus-3. (1999) (25)
Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV (2005) (25)
Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres. (2002) (25)
Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models. (2006) (24)
Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells. (2010) (24)
Pathological changes in bovine mammary glands following intramammary infusion of recombinant interleukin-2. (1991) (24)
Synthesis and processing of the haemagglutinin-esterase glycoprotein of bovine coronavirus encoded in the E3 region of adenovirus. (1992) (24)
The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle. (1983) (24)
Bovine gut-associated lymphoid tissue--morphologic and functional studies. I. Isolation and characterization of leukocytes from the epithelium and lamina propria of bovine small intestine. (1987) (24)
Safety of CpG oligodeoxynucleotides in veterinary species. (2003) (24)
Induction of mucosal immunity in cotton rats to haemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus. (1995) (23)
Functional and phenotypic characteristics of bovine natural cytotoxic cells. (1985) (23)
c-di-GMP Enhances Protective Innate Immunity in a Murine Model of Pertussis (2014) (23)
Studies on rotaviral antibody in bovine serum and lacteal secretions, using radioimmunoassay. (1978) (23)
Polymorph-mediated antibody-dependent cytoxicity--modulation of activity by drugs and immune interferon. (1976) (23)
Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes. (1992) (23)
Mucosal dendritic cell subpopulations in the small intestine of newborn calves. (2011) (23)
Lymphocyte proliferative responses to recombinant bovine herpes virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: identification of a T cell epitope. (1995) (23)
In vitro and systemic effects of recombinant bovine interferons on natural cell-mediated cytotoxicity in healthy and bovine herpesvirus-1-infected cattle. (1985) (22)
Synthesis, cellular location, and immunogenicity of bovine herpesvirus 1 glycoproteins gI and gIII expressed by recombinant vaccinia virus (1989) (22)
Pseudorabies virus gIII and bovine herpesvirus 1 gIII share complementary functions (1991) (22)
A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection. (2010) (22)
Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination. (2001) (22)
Bovine t lymphocytes--an improved technique of E rosette formation. (1978) (22)
Bovine coronavirus nonstructural protein ns2 is a phosphoprotein (1991) (22)
Interactions between effector cell activity and lymphokines: implications for recovery from herpesvirus infections. (1978) (22)
Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages (1975) (22)
Nucleic acid vaccines: veterinary applications. (1998) (22)
Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice. (2017) (22)
Vaccination in conservation medicine. (2007) (22)
Characterization of surface markers of bovine gut mucosal leukocytes using monoclonal antibodies. (1989) (21)
Neuroimmunomodulation of in vivo anti-rotavirus humoral immune response (1990) (21)
Intercellular trafficking of the major tegument protein VP22 of bovine herpesvirus-1 and its application to improve a DNA vaccine (2006) (21)
Plasmid DNA induces increased lymphocyte trafficking: a specific role for CpG motifs. (2001) (21)
Immunization with a dicistronic plasmid expressing a truncated form of bovine herpesvirus-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses. (2003) (21)
Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice. (1999) (21)
Molecular analyses of disease pathogenesis: Application of bovine microarrays (2005) (21)
Sequence and transcription map analysis of early region-1 of porcine adenovirus type-3. (1998) (21)
Prevalence and risk factor investigation of Campylobacter species in beef cattle feces from seven large commercial feedlots in Alberta, Canada. (2009) (21)
The role of biological response modifiers in disease control. (1993) (21)
Activation and regulation of toll-like receptor 9: CpGs and beyond. (2008) (21)
Heterotypic Passive Protection Induced by Synthetic Peptides Corresponding to VP7 and VP4 of Bovine Rotavirus (1992) (21)
Expression of tumor necrosis factor-alpha receptors on bovine macrophages, lymphocytes and polymorphonuclear leukocytes, internalization of receptor-bound ligand, and some functional effects. (1990) (21)
Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs. (2008) (20)
Bovine rotavirus-cell interactions: effect of virus infection on cellular integrity and macromolecular synthesis. (1981) (20)
The adjuvant PCEP induces recruitment of myeloid and lymphoid cells at the injection site and draining lymph node. (2014) (20)
Complement-dependent, polymorphonuclear neutrophil-mediated cytotoxicity of herpesvirus-infected cells: possible mechanism(s) of cytotoxicity. (1980) (20)
Passively acquired membrane proteins alter the functional capacity of bovine polymorphonuclear cells (2006) (20)
Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c. (2005) (20)
Human neutrophil--mediated destruction of antibody sensitized herpes simplex virus type I infected cells. (1978) (20)
Novel viral vaccines for livestock. (1996) (20)
Molecular chimerization of Pasteurella haemolytica leukotoxin to interleukin-2: effects on cytokine and antigen function (1992) (19)
Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression. (2008) (19)
The sequence of cDNA of bovine coronavirus 32K nonstructural gene. (1989) (19)
Molecular approaches to disease control. (2003) (19)
Cell-mediated cytotoxic responses in lungs following a primary bovine herpes virus type 1 infection. (1992) (19)
Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins. (1999) (19)
ProbeLynx: a tool for updating the association of microarray probes to genes (2004) (19)
Molecular mimicry: a herpes virus glycoprotein antigenically related to a cell-surface glycoprotein expressed by macrophages, polymorphonuclear leucocytes, and platelets. (1990) (19)
Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets (2017) (19)
Sequence and expression of a bovine herpesvirus-1 gene homologous to the glycoprotein K-encoding gene of herpes simplex virus-1. (1996) (19)
Solid-Phase Radioimmunoassay for Detecting Bovine (Neonatal Calf Diarrhea) Rotavirus Antibody (1977) (19)
DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice. (1997) (18)
Functional analysis of the transmembrane anchor region of bovine herpesvirus 1 glycoprotein gB. (1997) (18)
Inclusion of the Bovine Neutrophil Beta-Defensin 3 with Glycoprotein D of Bovine Herpesvirus 1 in a DNA Vaccine Modulates Immune Responses of Mice and Cattle (2014) (18)
Optimization of a DNA vaccine against SARS. (2007) (18)
Glycoprotein Bb, the N-terminal subunit of bovine herpesvirus 1 gB, can bind to heparan sulfate on the surfaces of Madin-Darby bovine kidney cells (1996) (18)
Surface Antigen Expresion by Bovine Alveolar Macrophages: Functional Correlation and Influence of Interferons In Vivo and In Vitro (1986) (18)
Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection (1995) (18)
Analysis of the S spike (peplomer) glycoprotein of bovine coronavirus synthesized in insect cells (1990) (17)
Effect of recombinant bovine interleukin-1 beta on viral/bacterial pneumonia in cattle. (1995) (17)
Observations on recovery mechanisms from feline viral rhinotracheitis. (1976) (17)
Direct lymphocytotoxicity against herpes simplex virus infected cells. (1978) (17)
Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: effect of antigen form on the induction of cellular and humoral immune responses. (1996) (17)
Influenza A virus NS 1 protein activates the phosphatidylinositol 3-kinase ( PI 3 K ) / Akt pathway by direct interaction with the p 85 subunit of PI 3 K (2006) (16)
In vitro generation of hydrogen peroxide and of superoxide anion by bovine polymorphonuclear neutrophilic granulocytes, blood monocytes, and alveolar macrophages (1984) (16)
Predictors of influenza a molecular viral shedding in Hutterite communities (2017) (16)
Letter: Test for reovirus-like agent. (1975) (16)
Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial (2016) (16)
4 – Recombinant Cytokines and their Therapeutic Value in Veterinary Medicine (1989) (15)
Intranasal immunization of mice against Pasteurella multocida (1981) (15)
The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells. (2011) (15)
Transcriptome studies on Streptococcus pneumoniae, illustration of early response genes to THP-1 human macrophages. (2009) (15)
In vitro assembly of the outer capsid of bovine rotavirus is calcium-dependent. (1988) (15)
TLR9 Signaling Failure Renders Peyer’s Patch Regulatory B Cells Unresponsive to Stimulation with CpG Oligodeoxynucleotides (2010) (15)
All three classes of CpG ODNs up-regulate IP-10 gene in pigs. (2010) (15)
Bovine peripheral blood leukocyte population dynamics following treatment with recombinant bovine interferon-alpha I1. (1989) (14)
Generation of IL-2 dependent bovine cytotoxic T lymphocyte clones reactive against BHV-1 infected target cells: loss of genetic restriction and virus specificity. (1987) (14)
Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene. (1996) (14)
Bovine herpesvirus-1 US3 protein kinase: critical residues and involvement in the phosphorylation of VP22. (2010) (14)
Immunization ofCalves Against Enterotoxigenic Colibacillosis byVaccinating DamswithPurified K99Antigen andWhole Cell Bacterinst (1979) (14)
Polymorphonuclear neutrophil-mediated antibody-dependent cell cytotoxicity of herpesvirus-infected cells: ultrastructural studies. (1980) (14)
A neutrophil-derived antiviral protein: induction requirements and biological properties (1989) (14)
Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes. Colostral neutralizing antibody by rotavirus VP8*. (1997) (14)
Bovine lymphocyte antigen-A11--specific peptide motif as a means to identify cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1. (1999) (14)
Hepatitis C virus non-structural protein-2 activates CXCL-8 transcription through NF-kappaB. (2008) (14)
Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses. (1985) (13)
Mapping of neutralizing epitopes to fragments of the bovine coronavirus E2 protein by proteolysis of antigen-antibody complexes. (1989) (13)
Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies. (2008) (13)
Induction, isolation and surface marker studies on bovine eosinophils. (1979) (13)
Mutational analysis of early region 4 of bovine adenovirus type 3. (2001) (13)
Lymphocyte activation by cell separation procedures. (1976) (13)
Immune Responses to Synthetic Peptide Vaccines of Veterinary Importance (1988) (13)
Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A. (2010) (13)
A slow release formulation for recombinant bovine interferon αI-1 (1994) (13)
Expression of Bovine Interleukin-1β in a Bovine Herpesvirus-1 Vector:In VitroAnalysis (1996) (13)
CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands. (2008) (13)
Microarray analysis of gene expression following preparation of sterile intestinal “loops” in calves (2005) (13)
Caspase-1 Dependent IL-1β Secretion and Antigen-Specific T-Cell Activation by the Novel Adjuvant, PCEP (2014) (13)
Immune mechanisms against canine distemper. I. Identification of K cell against canine distemper virus infected target cells in vitro. (1979) (13)
Induction of immunity in the respiratory tract and protection from bovine herpesvirus type 1 infection by different routes of immunization with recombinant adenovirus. (1998) (13)
Isolation of various canine leucocytes and their characterization by surface marker analysis. (1978) (13)
Bovine adenovirus type 3 E1B(small) protein is essential for growth in bovine fibroblast cells. (2001) (13)
Peanut agglutinin (PNA): binding and stimulation of bovine intestinal and peripheral blood leukocytes. (1989) (13)
Immune mechanisms against canine distemper. II. Role of antibody in antigen modulation and prevention of intercellular and extracellular spread of canine distemper virus. (1979) (13)
Studies on the in vitro biological activities of recombinant bovine tumor necrosis factor (rBoTNF) alpha. I. Synergistic antiviral efficacy of rBoTNF alpha, recombinant bovine interferon gamma (rBoIFN gamma) and their combination. (1988) (12)
Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation (2011) (12)
Induction of MHC class II antigens on bovine cells of nonlymphoid origin by recombinant bovine interferon-gamma and tumor necrosis factor-alpha. (1988) (12)
Activity of polymorphonuclear (PMN) leukocytes during bovine herpes virus-1 induced respiratory disease: effect of recombinant bovine interferon alpha I1. (1987) (12)
Capture immunoassay for ruminant tumor necrosis factor-alpha: comparison with bioassay. (1993) (12)
Immune effector cell activity in canines: failure to demonstrate genetic restriction in direct antiviral cytotoxicity (1978) (12)
Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4. (1995) (12)
Bovine rotavirus diagnosis: comparison of various antigens and serological tests (1978) (12)
Regulation of major histocompatibility complex class II expression by Pasteurella haemolytica leukotoxin (1994) (12)
Infectious bovine rhinotracheitis (bovine herpesvirus 1) : helper T cells, cytotoxic T cells, and NK cells (1994) (12)
Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity. (1996) (12)
Therapeutic and prophylactic effects of some antibiotics on experimental pneumonic pasteurellosis. (1984) (11)
Alveolar macrophage characteristics: effect of repeated lavages on cell activity. (1986) (11)
Effect of anti-herpesvirus drugs on human and bovine lymphoid function in vitro (1975) (11)
The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries (2011) (11)
Multiple molecular regions confer intracellular localization of bovine Toll-like receptor 8. (2009) (11)
Recombinant Bovine Adenovirus-3 Co-Expressing Bovine Respiratory Syncytial Virus Glycoprotein G and Truncated Glycoprotein gD of Bovine Herpesvirus-1 Induce Immune Responses in Cotton Rats (2014) (11)
Antigen-specific cytokine and antibody isotype profiles induced by mucosal and systemic immunization with recombinant adenoviruses. (1999) (11)
Editorial: DNA Vaccination: A Simple Concept with Challenges Regarding Implementation (2006) (11)
Effect of dexamethasone on bovine leukocyte functions and bovine herpesvirus type-1 replication. (1987) (11)
Mucosal immunization of calves with recombinant bovine adenovirus-3 coexpressing truncated form of bovine herpesvirus-1 gD and bovine IL-6. (2014) (11)
Studies on the occurrence and significance of bovine respiratory syncytial virus in Saskatchewan. (1978) (11)
Veterinary applications of DNA vaccines. (2000) (11)
Genome-wide Expression Analyses of Campylobacter jejuni NCTC11168 Reveals Coordinate Regulation of Motility and (2004) (11)
Experimental inoculation of heifers with bovine adenovirus type 3. (1999) (11)
DNA immunization: present and future. (1999) (11)
Expression of bovine interleukin-1 beta in a bovine herpesvirus-1 vector: in vitro analysis. (1996) (11)
B-cell activating factor (BAFF) promotes CpG ODN-induced B cell activation and proliferation. (2011) (11)
Differential display analysis of gene expression during the induction of mucosal immunity (2000) (10)
The cell-mediated immune response induced by plasmid encoding bovine herpesvirus 1 glycoprotein B is enhanced by plasmid encoding IL-12 when delivered intramuscularly or by gene gun, but not after intradermal injection. (2006) (10)
Bovine interferon-alphaI 1 is an effective inhibitor of bovine herpes virus-1 induced respiratory disease. (1985) (10)
Bovine herpesvirus-1 VP8 interacts with DNA damage binding protein-1 (DDB1) and is monoubiquitinated during infection. (2012) (10)
Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep. (2007) (10)
Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome (2012) (10)
Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4. (1998) (10)
Preparation, purification and characterization of bovine Peyer's patch leukocytes. (1988) (10)
Subcutaneous, but not intratracheal administration of the TLR9 agonist, CpG DNA transiently reduces parainfluenza-3 virus shedding in newborn lambs. (2010) (10)
Polynucleotide vaccines: potential for inducing immunity in animals. (1999) (10)
Restrictions on the Importation of Zebrafish into Canada Associated with Spring Viremia of Carp Virus. (2016) (9)
Long-term culture of canine peripheral blood monocytes in vitro. (1979) (9)
Characterization and activation requirements of bovine lymphocytes acquiring cytotoxic activity after interleukin-2 treatment. (1992) (9)
Surface antigen expression by bovine alveolar macrophages: functional correlation and influence of interferons in vivo and in vitro. (1986) (9)
Trypanosoma theileri associated with T-lymphocytes isolated from a latently infected cow. (1989) (9)
Immunosuppression by Bovine Herpesvirus 1 and Other Selected Herpesviruses (1989) (9)
Prevalence and risk factor investigation of Campylobacter species in retail ground beef from Alberta, Canada. (2009) (9)
Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration. (2004) (9)
Intracellular trafficking of VP22 in bovine herpesvirus-1 infected cells. (2010) (9)
Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes. (1992) (9)
Rotavirus Isolation andCultivation inthePresence ofTrypsin (1977) (9)
Characterization of the bovine secondary in vitro antibody response. (1984) (8)
Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3 (2000) (8)
In vitro culture characteristics of bovine alveolar macrophages. (1982) (8)
Negative enrichment of bovine T lymphocytes with monoclonal antibodies and magnetic microspheres. (1989) (8)
Needle-free delivery of veterinary DNA vaccines. (2006) (8)
Trypsin and bovine rotavirus replication (1978) (8)
Mechanisms of viral immunopathology. (1979) (8)
Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. (1989) (8)
Clinical and pathological evaluation of sulbactam/ampicillin for treatment of experimental bovine pneumonic pasteurellosis. (1988) (8)
Analysis of early region 4 of porcine adenovirus type 3. (2004) (8)
Potential of Polyphosphazenes in Modulating Vaccine‐Induced Immune Responses: II. Investigations in Large Animals (2008) (7)
A new plaque system for canine distemper: characteristics of the green strain of canine distemper virus. (1979) (7)
A dose‐ranging study of ranitidine and its effect on intragastric and intra‐oesophageal acidity in subjects with gastro‐oesophageal reflux disease (1994) (7)
Interferon-gamma and B-cell Activating Factor (BAFF) promote bovine B cell activation independent of TLR9 and T-cell signaling. (2012) (7)
Interaction of VP8 with mRNAs of bovine herpesvirus-1. (2015) (7)
Special Issues around Veterinary Vaccines (2009) (7)
Genetic Organization and DNA Sequence of Early Region 4 of Bovine Adenovirus Type 3 (2004) (7)
Amended recombinant cells (ARCs): an economical and surprisingly effective production and delivery vehicle for recombinant bovine IFN-gamma. (2005) (7)
Physiological and morphological changes in bovine mammary glands following intramammary infusion of recombinant interferon-gamma. (1992) (7)
Immunogenicity of a Bovine Herpesvirus 1 Glycoprotein D DNA Vaccine Complexed with Bovine Neutrophil Beta-Defensin 3 (2014) (7)
The adjuvant potential of cytokines. (1992) (7)
Immunogenicity of the capsid protein VP2 from porcine parvovirus expressed in low alkaloid transgenic tobacco (2003) (7)
2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator? (1989) (7)
Clinical and immunological effects of single bolus administration of recombinant interleukin-2 in cattle. (1992) (7)
Immune mechanisms against canine distemper. III. Role of complement lysis in the immunity and persistent infection of canine distemper virus. (1980) (7)
DNA vaccination in utero: a new approach to induce protective immunity in the newborn. (2004) (7)
Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation. (2007) (7)
Characterization of Bovine Adenovirus Type 3 Early Region 2B (2004) (6)
The cytoplasmic domain of bovine herpesvirus 1 glycoprotein B is important for maintaining conformation and the high-affinity binding site of gB. (1996) (6)
Oral DNA immunization in the second trimester fetal lamb and secondary immune responses in the neonate. (2007) (6)
121R Protein from the E3 Region of Bovine Adenovirus-3 Inhibits Cytolysis of Mouse Cells by Human Tumor Necrosis Factor (2001) (6)
New approaches for antigen discovery, production and delivery: vaccines for veterinary and human use. (2001) (6)
The role of bovine intraepithelial leukocyte-mediated cytotoxicity in enteric antiviral defense. (1992) (6)
An impedimetric biosensor for COVID-19 serology test and modification of sensor performance via dielectrophoresis force (2022) (6)
Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor (1993) (6)
Viral-Bacterial Synergistic Interactions/Pathogenesis in Cattle (1995) (6)
2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha. (1989) (6)
Effects of BHV-1 on PMN adhesion to bovine lung endothelial cells. (1996) (6)
Characterization of the interaction between VP8 of bovine rotavirus C486 and cellular components on MA-104 cells and erythrocytes. (1998) (6)
Non-major histocompatibility complex-restricted cytotoxicity of bovine coronavirus-infected target cells mediated by bovine intestinal intraepithelial leukocytes. (1991) (6)
Veterinary DNA vaccines. (2000) (5)
Ribonucleotides in infectious bovine rhinotracheitis virus DNA. (1976) (5)
Virus-Induced Gastroenteritis in Animals (1984) (5)
Effects of recombinant bovine interferons-α and -γ on some in vitro immune functions of bovine intraepithelial and lamina propria leukocytes (1988) (5)
Recombinant human interleukin-2-induced mitogenic proliferation of in vitro unstimulated bovine intestinal lymphocytes. (1989) (5)
A slow release formulation for recombinant bovine interferon alpha I-1. (1994) (5)
POSSIBLE MECHANISM OF ROTAVIRUS PERSISTENCE (1980) (5)
Characteristics of respiratory viral infections during influenza season in Canadian Hutterite Communities (2012) (4)
Primary Structure of the S peplomer gene of bovine coronavirus and surface expression in insect cells. (1990) (4)
Amended recombinant cells (ARCs) expressing bovine IFN-gamma: an economical and highly effective adjuvant system. (2009) (4)
Cellular interactions in the generation of bovine Con A-suppressor cells and in the mitogenic proliferative response. (1984) (4)
Biphasic lipid vesicles as a subcutaneous delivery system for protein antigens and CpG oligonucleotides. (2006) (4)
Future vaccines for a globalized world (2012) (4)
Infection of canine mononuclear leucocytes by measles virus: possible mechanism of protection from canine distemper. (1981) (4)
Potentiation of Vaccines Through Effective Adjuvant Formulations and Manipulation of the Immune Response (1994) (4)
Utilization of RNA polymerase I promoter and terminator sequences to develop a DNA transfection system for the study of hepatitis C virus internal ribosomal entry site-dependent translation. (2007) (4)
Zinc-binding of the cysteine-rich domain encoded in the open reading frame of 1B of the RNA polymerase gene of coronavirus. (1995) (4)
Effect of recombinant bovine interleukin-1 beta in normal calves and in calves infected with bovine herpesvirus type 1. (1996) (4)
Animal biotechnology : Comprehensive biotechnology. First supplement (1989) (4)
26 – Viral–Bacterial Synergistic Interactions in Respiratory Infections (1984) (4)
Animal genomics for animal health report: critical needs, problems to be solved, potential solutions, and a roadmap for moving forward. (2008) (4)
Response of bovine intestinal leukocytes to recombinant bovine interleukin-2. (1988) (4)
A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells. (1998) (4)
Equine respiratory disease on the Western Canadian racetracks. (1979) (4)
Efficacy of 5-methoxymethyl-2'-deoxyuridine in combination with arabinosyladenine for the treatment of primary herpes simplex genital infection of mice and guinea pigs. (1986) (3)
Cell-fusion properties of Sendai virus prepared by polyethylene-glycol precipitation. (1972) (3)
IL-10 secreting CD21+ B cells are present in jejunal Peyer’s patches of sheep during fetal development (2014) (3)
Effect of levamisole and bovine interferon alpha 1 on bovine immune responses and susceptibility to bovine herpesvirus-1. (1984) (3)
Demonstration of the in vitro antiviral properties of bovine lymphokine-activated killer (LAK) cells. (1991) (3)
Murine cytomegalovirus-Pseudomonas synergistic infections: comparison of virulent and attenuated virus. (1987) (3)
Effects of recombinant bovine interferons-alpha and -gamma on some in vitro immune functions of bovine intraepithelial and lamina propria leukocytes. (1988) (3)
Evidence for the existence of regulatory and effector B cell populations in Peyer's patches of sheep. (2016) (3)
The Host Signaling Pathways Hijacked by Oncogenic Viruses (2017) (3)
Characterization of a synthetic peptide mimicking trypsin-cleavage site of rotavirus VP4. (1995) (3)
The abp locus of Streptococcus uberis encodes a protein homologous to polar amino acid and opine binding proteins of gram-negative bacteria. (1998) (3)
Protection of Chickens against a Lethal Challenge of Escherichia coli by a Vaccine Containing CpG Oligodeoxynucleotides (CpG-ODN) as an Adjuvant (2007) (3)
Erratum to “Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery” ☆: [Journal of Controlled Release 66 (2000) 199–214] (2000) (3)
Mucosal Vaccine Development for Veterinary and Aquatic Diseases (2019) (3)
Interleukin-2 production by mitogen-stimulated intestinal mucosal leukocytes from cattle. (1989) (2)
Comparison of bovine immune responses to affinity-purified bovine herpesvirus-1 antiidiotypes and glycoproteins. (1993) (2)
Determining optimal community protection strategies for the influenza vaccine (2019) (2)
The haemagglutinin of bovine coronavirus exhibits significant similarity to the haemagglutinin of type C influenza virus. (1990) (2)
Properties of polyoma virus transformed cells. I. Oncogenic properties. (1971) (2)
Production and characterization of bovine herpesvirus 1 glycoprotein B ectodomain derivatives in an hsp70A gene promoter-based expression system (2005) (2)
Characterization of two rotaviruses differing in their in vitro and in vivo virulence. (1993) (2)
Yeasts of the matador soils of Saskatchewan and their ability to use flavonoids. (1971) (2)
Gemini nanoparticles as a co-delivery system for antigen – CpG oligodeoxynucleotide adjuvant combination (2010) (2)
The effect of the antiherpesvirus drug 5-methoxymethyl-2'-deoxyuridine on the humoral immune response in vivo. (1977) (2)
Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial. (2021) (2)
CSCI/RCPSC Henry Friesen lecture: controlling infectious diseases through vaccination. (2014) (2)
Mechanisms of heterotypic immunity against canine distemper (1979) (2)
New Applications for Health and Innovation in Veterinary Medicine (2006) (2)
Conventional and Biotechnologically Engineered Bovine Vaccines (1993) (2)
752 THERAPEUTIC VACCINATION FOR CHRONIC HEPATITIS B (CHB) USING HETEROLOGOUS PROTEIN PRIME/VECTOR BOOST VACCINATION SCHEME (2013) (1)
Concanavalin A-induced suppressor cell activity in intestinal mucosal leukocytes obtained from healthy cows. (1989) (1)
Immunity to viral infections (1990) (1)
Functional Characterization of Bovine Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase and Fusion Proteins Expressed by Adenovirus Recombinants (1999) (1)
Viral Gastroenteritis in Ruminants (1990) (1)
Neutrophils are mediators of antiviral immunity (1978) (1)
Hemagglutinin-esterase glycoprotein gene of bovine corona virus delivered by adenovirus vector induces mucosal immunity in cotton rats. (1997) (1)
Modulation of some Peyer's patch leukocyte functions following in vitro exposure to recombinant bovine alpha- and gamma-interferon. (1988) (1)
Perspectives for the Treatment of Gastrointestinal Tract Virus Infections (1988) (1)
Inhibition of polyoma virus development in mouse-hamster heterokaryons. (1973) (1)
Categories of products (mechanisms of action, advantages/disadvantages) (1997) (1)
3rd World Congress on Vaccines and Immunisation (2002) (1)
Effect of stress on viral–bacterial synergy in bovine respiratory disease: novel mechanisms to regulate inflammation: Conference Papers (2005) (1)
Isolation, characterization and in vitro mitogenic stimulation of peripheral blood lymphocytes from an American buffalo. (1989) (1)
Detection of Viral Antigens and Antibodies (1989) (1)
Modulation of the in vivo anti-rotavirus humoral immune response by neuroendocrines and neuropeptides (1990) (1)
Potential of Polyphosphazenes in Modulating Vaccine‐Induced Immune Responses: I. Investigations in Mice (2008) (1)
CpG Oligodeoxynucleotides Activate Innate Immune Response that Suppresses Infectious Bronchitis Virus Replication in Chicken Embryos (2009) (1)
Host Responses to Infectious Bovine Rhinotracheitis Virus (1974) (1)
Improving immunoassay detection accuracy of anti-SARS-CoV-2 antibodies through dual modality validation (2022) (1)
Interaction of cytokines and leukocytes in infectious diseases. (1990) (1)
Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants (2012) (1)
Recombinant assembled rotavirus proteins induce heterologous protection in a murine model (1992) (0)
Livestock Vaccines Against Viral Diseases for Developing Farmers in sub‐Saharan Africa : final technical report (March 2012 - August 2014) (2014) (0)
Vaccines for improving animal production. (1990) (0)
Vaccine delivery systems and immune regulation in modern immunization (1998) (0)
Expression andSecretion oftheBovineCoronavirus Hemagglutinin- Esterase Glycoprotein byInsect Cells Infected with Recombinant Baculovirusest (1990) (0)
Vaccination of Animals (2003) (0)
Elastase-Dependent Live Attenuated Swine Inﬂuenza A Viruses Are Immunogenic and Confer Protection against Swine Inﬂuenza A Virus Infection in Pigs (cid:1) (2009) (0)
SH3 Binding Motif 1 in Inﬂuenza A Virus NS1 Protein Is Essential for PI3K/Akt Signaling Pathway Activation (cid:1) (2007) (0)
Controlling acute experimental Escherichia coli mastitis with recombinant bovine interferon-gamma. (1990) (0)
Genome-wide Expression Analyses of Campylobacter jejuni NCTC11168 Reveals Coordinate Regulation of Motility and Virulence by flhA*□S (2004) (0)
Clinical signs and gross pathology in sheep and goats following infection with PPRV (Malig strain). (2014) (0)
Bovine herpesvirus type 1rekombinantenpolypeptide and vaccine (1992) (0)
Controlling Infectious Diseases through Vaccination (2014) (0)
DNA Vaccine in Sheep Humoral Immune Responses Induced by a Targeting with Bovine CD 154 Enhances (2002) (0)
Biotechnology Applied in Animal Vaccine Development and Production (1988) (0)
Multisystemic wasting by virus in pigs (1998) (0)
Regulation of Bovine Acute Phase Responses by Recombinant Interleukin- 11, (2005) (0)
CD14+ cells are required for TLR7/8 ligand-induced IL-12 and IFN-γ responses in bovine blood mononuclear cells (2009) (0)
Innate immune responses to viral infections: A story of Hepatitis C virus and host chemokines. Recent Developments in Immunology (2008) (0)
CIFSRF final technical report : vaccines for viral diseases of livestock in Africa (CIFSRF Phase 2) (2018) (0)
Natural and inducible regulatory B cells are widely distributed in ovine lymphoid tissues. (2019) (0)
Corrigendum to “Interaction of VP8 with mRNAs of bovine herpesvirus-1” [Virus Res. 197 (2015) 116–126] (2015) (0)
Vol. 41, 1998 (1999) (0)
Potentiation of the Immune Response by Cytokines (2020) (0)
Monographs in Virology - Volume 9. Early Interaction Between Animal Viruses and Cells (1975) (0)
Virus syndrome postweaning from pigs. (1998) (0)
Virus multisystemic Kümmersyndroms for weaners (1998) (0)
Advances in Viral Vaccine Technology (1988) (0)
Response from the authors (1985) (0)
Identification ofTrypanosoma theileri as a contaminant in primary cultures of bovine retina (1978) (0)
Single-dose vaccines save livestock and livelihoods in Sub-Saharan Africa : project profile (2018) (0)
in-vivoおよびin-vitroにおける病原性が異なる2種のロタウイルスの性状 (1993) (0)
Host-microbe interactions: fungi/viruses/parasites (1998) (0)
656 HEPATITIS C VIRUS GENOTYPE-3A NS5A PROTEIN ACTIVATES STEROL REGULATORY ELEMENT-BINDING PROTEIN-1 (2010) (0)
Studies on the transformation of mammalian cells by polyoma virus (1972) (0)
Detection of viral antigens and antibodies. Enzyme immunoassays. (1989) (0)
Detection byRadioimmunoassay andEnzyme-Linked Immunosorbent AssayofCoronavirus Antibodies inBovine SerumandLacteal Secretions (1982) (0)
UseofRecombinant BovineAlpha, Interferon inReducing Respiratory Disease Induced byBovine Herpesvirus Typeit (1987) (0)
Interleukin 2 (1990) (0)
SEVERE ACUTE RESPIRATORY SYNDROME (SARS): AY ear in Review (2005) (0)
Veterinary vaccines (1994) (0)
Subject Index Vol. 41, 1998 (1999) (0)
Polypeptides and recombinant vaccines against bovine herpesvirus type 1. (1992) (0)
A process for the preparation of a recombinant vector rinderadenovirus (1998) (0)
Protection of Neonatal Broiler Chicks against Salmonella Typhimurium Septicemia by DNA Containing CPG Motifs (2008) (0)
Global food securities : is vaccination an answer? (2013) (0)
Postweaning multisystemic wasting syndrome virus (PMWS) by porcine (1998) (0)
The synthesis of viral- and cellular-DNA in mammalian cells exposed to polyoma virus (2005) (0)
Defining a standard and weighted mathematical index for maturation of dendritic cells (2018) (0)
Sheep and goat pox viral diagnostics and vaccine development collaboration (2012) (0)
Medicine in the daily life of women of the Soviet Ukraine in the NEP period (2017) (0)
Histology and immunohistochemistry of sheep and goat tissue at varying time points following infection with PPRV (Malig strain). (2014) (0)
3rd World Congress on Vaccines and Immunisation. June 4-9 2002, Opatija Adriatic Riviera, Croatia. (2002) (0)
Virus multisystemic syndrome postweaning from pigs (1998) (0)
Antimicrobial Activities of Phytochemicals from British Columbian Medicinal Plants (2018) (0)
DNA vaccine combined with heterologous boosting as a promising vaccination strategy - hepatitis C as a model. (2007) (0)
Corrigendum to Intracellular trafficking ofVP22 in bovine herpesvirus-1 infected cells (2010) (0)
United States Patent ( 19 ) Parker et al . ( 54 ) DNA ENCODING BOVINE CORONAVIRUS POLYPEPTIDES E 2 AND E 3 (2017) (0)
Corrigendum to “Intracellular trafficking of VP22 in bovine herpesvirus-1 infected cells” [Virology 396 (2010) 189–202] (2010) (0)
ILRI 40 years: Healthy animals equals healthy, productive people (2014) (0)
Helper-Independent Live Recombinant Adenovirus Vector Expressing the Hemagglutinin-Esterase Membrane Glycoprotein (1992) (0)
Transcription mapping and characterization of proteins produced from early region 4 of porcine adenovirus type 3 (2006) (0)
Potentials of synthetic peptides as rotavirus vaccine and therapy (1992) (0)
Interleukin 2 (2020) (0)
Vaccines: Alternatives to Antimicrobials to Control Diseases of Cattle (2004) (0)
Novel approaches for developing vaccines (1998) (0)
Prospects and challenges for the development of DNA-based vaccines and therapeutics. (2007) (0)
Preparation of a dane core (hepatitis B) antigen from human plasma. (1975) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lorne Allan Ben Babiuk?

Lorne Allan Ben Babiuk is affiliated with the following schools:

Lorne Allan Ben Babiuk's Academic­Influence.com Rankings

Why Is Lorne Allan Ben Babiuk Influential?

Lorne Allan Ben Babiuk's Published Works

Published Works

What Schools Are Affiliated With Lorne Allan Ben Babiuk?

Lorne Allan Ben Babiuk's AcademicInfluence.com Rankings